SV

Street Verdict

Analyst Scorecard

A record of what Nilesh Shah said publicly, with the source. Not advice.

Pending — not yet graded
“Expects sectoral rotation within Pharma, favoring domestic-focused and CDMO (Contract Development and Manufacturing Organization) players in 2026. Generic exporters to the US market may lag behind these segments.”
Nifty PharmaBullishCalled 29 Dec 2025
Verdict:PENDING

How this relative call is judged

A relative call is a comparison, judged on closing prices from the first close after the call to the end of its window (3 months when the quote states no time frame). The spread is the pick's return minus the comparator's return: above zero is a hit for a call that favours the pick, and the reverse for a call that marks it down.

Window still open: no verdict until it ends.

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Nilesh Shah’s full track record